Ophthalmology Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery

Nov 2020| MKB187F| TBRC (Publisher)

Report Highlights

Including: Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); Antiglaucoma Drugs; Dry Eye Medication

Covering: Regeneron Pharmaceuticals, Inc.; Novartis AG; Allergan Plc.; Santen Pharmaceutical Co.; F. Hoffmann-La Roche Ltd

Regeneron Pharmaceuticals, Inc. was the largest competitor with 23.66% of the market followed by Novartis AG and Allergan Plc.

Ophthalmology Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs sector.

Reasons to Purchase

  • Fully updated for 2020 including the impact of the Covid 19/ Novel Coronavirus.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and key trends
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.

Description

Ophthalmology Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery from the Business Research Company covers market characteristics, size and growth for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the ophthalmology drugs market revenues, covering both the historic growth of the market and forecasting the future. 

ophthalmology drugs market

Scope

Markets Covered: Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); Antiglaucoma Drugs; Dry Eye Medication

Companies: Regeneron Pharmaceuticals, Inc.; Novartis AG; Allergan Plc.; Santen Pharmaceutical Co.; F. Hoffmann-La Roche Ltd

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa

Time series: Five years historic and forecast
Data: Market value in $ billions.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Ophthalmology Drugs Market, Historic Market Size, 2015-2019, $ Billion
  • Table 2 : Global Ophthalmology Drugs Market, Forecast Market Size, 2019-2023, $ Billion
  • Table 3 : Global Ophthalmology Drugs Market, Key Competitors Estimated Market Shares, 2019, Percentage (%)
  • Table 4 : Regeneron – Financial Performance, $ Billion
  • Table 5 : Novartis – Financial Performance, $ Billion
  • Table 6 : Allergan – Financial Performance, $ Billion
  • Table 7 : Ophthalmology Drugs Market Data Sources
  • Figure 1 : Global Ophthalmology Drugs Market, Historic Market Size, 2015-2019, $ Billion
  • Figure 2 : Global Ophthalmology Drugs Market, Forecast Market Size, 2019-2023, $ Billion
  • Figure 3 : Global Ophthalmology Drugs Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 4 : Regeneron – Financial Performance, $ Billion
  • Figure 5 : Novartis – Financial Performance, $ Billion
  • Figure 6 : Allergan – Financial Performance, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report